Disclosures for "A Novel Prospective Study Design Evaluating Impact of Plasma P-tau217 Testing on Early Evaluation and Management of Patients in Primary and Secondary/Tertiary Care Private Practices"
-
Dr. Sandoval has received personal compensation for serving as an employee of Eli Lilly. Dr. Sandoval has or had stock in Eli Lilly.
-
Mr. Spargo has received personal compensation for serving as an employee of Eli Lilly. Mr. Spargo has stock in Eli Lilly.
-
Ms. Lu has received personal compensation for serving as an employee of Sanofi US Services Inc.. Ms. Lu has stock in Eli Lilly and Company.
-
Dr. Sireci has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sireci has stock in Eli Lilly and Company.
-
Mrs. Morris has received personal compensation for serving as an employee of Eli Lilly . Mrs. Morris has stock in Eli Lilly.
-
Dr. Hartry has received personal compensation for serving as an employee of Eli Lilly & Co. Dr. Hartry has stock in Eli Lilly & Co.
-
Dr. Burnham has received personal compensation for serving as an employee of Eli Lilly. Dr. Burnham has stock in Eli Lilly. Dr. Burnham has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Hendrix has received personal compensation for serving as an employee of Eli Lilly & Company. Mr. Hendrix has stock in Eli Lilly and Company.
-
Dr. Beck has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Beck has stock in Eli Lilly and Co.